Equillium (EQ) Return on Capital Employed (QoQ) (2019 - 2026)
Equillium (EQ) Return on Capital Employed (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,194.00 |
| Dec 31, 2025 | 4,161.00 |
| Sep 30, 2025 | 15,962.00 |
| Jun 30, 2025 | -18,472.00 |
| Mar 31, 2025 | -5,969.00 |
| Dec 31, 2024 | -1,040.00 |
| Sep 30, 2024 | 1,760.00 |
| Jun 30, 2024 | 1,100.00 |
| Mar 31, 2024 | 426.00 |
| Dec 31, 2023 | -2,516.00 |
| Sep 30, 2023 | 1,494.00 |
| Jun 30, 2023 | 14,021.00 |
| Mar 31, 2023 | 144,534.00 |
| Dec 31, 2022 | -127,641.00 |
| Sep 30, 2022 | 54,852.00 |
| Jun 30, 2022 | -74,328.00 |
| Mar 31, 2022 | -11,433.00 |
| Dec 31, 2021 | -607.00 |
| Sep 30, 2021 | -758.00 |
| Jun 30, 2021 | 113.00 |